Skip to main content Accessibility help

n-3 PUFA: bioavailability and modulation of adipose tissue function: Symposium on ‘Frontiers in adipose tissue biology’

  • Jan Kopecky (a1), Martin Rossmeisl (a1), Pavel Flachs (a1), Ondrej Kuda (a1), Petr Brauner (a1), Zuzana Jilkova (a1), Barbora Stankova (a2), Eva Tvrzicka (a2) and Morten Bryhn (a3)...


Adipose tissue has a key role in the development of metabolic syndrome (MS), which includes obesity, type 2 diabetes, dyslipidaemia, hypertension and other disorders. Systemic insulin resistance represents a major factor contributing to the development of MS in obesity. The resistance is precipitated by impaired adipose tissue glucose and lipid metabolism, linked to a low-grade inflammation of adipose tissue and secretion of pro-inflammatory adipokines. Development of MS could be delayed by lifestyle modifications, while both dietary and pharmacological interventions are required for the successful therapy of MS. The n-3 long-chain (LC) PUFA, EPA and DHA, which are abundant in marine fish, act as hypolipidaemic factors, reduce cardiac events and decrease the progression of atherosclerosis. Thus, n-3 LC PUFA represent healthy constituents of diets for patients with MS. In rodents n-3 LC PUFA prevent the development of obesity and impaired glucose tolerance. The effects of n-3 LC PUFA are mediated transcriptionally by AMP-activated protein kinase and by other mechanisms. n-3 LC PUFA activate a metabolic switch toward lipid catabolism and suppression of lipogenesis, i.e. in the liver, adipose tissue and small intestine. This metabolic switch improves dyslipidaemia and reduces ectopic deposition of lipids, resulting in improved insulin signalling. Despite a relatively low accumulation of n-3 LC PUFA in adipose tissue lipids, adipose tissue is specifically linked to the beneficial effects of n-3 LC PUFA, as indicated by (1) the prevention of adipose tissue hyperplasia and hypertrophy, (2) the induction of mitochondrial biogenesis in adipocytes, (3) the induction of adiponectin and (4) the amelioration of adipose tissue inflammation by n-3 LC PUFA.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      n-3 PUFA: bioavailability and modulation of adipose tissue function
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      n-3 PUFA: bioavailability and modulation of adipose tissue function
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      n-3 PUFA: bioavailability and modulation of adipose tissue function
      Available formats


Corresponding author

*Corresponding author: Professor Jan Kopecky, fax +420 241062599, email


Hide All
1.Kopelman, PG (2000) Obesity as a medical problem Nature 404, 635643.
2.Kahn, SE, Hull, RL & Utzschneider, KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840846.
3.Tuomilehto, J, Lindstrom, J, Eriksson, JG et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344, 13431350.
4.Knowler, WC, Barrett-Connor, E, Fowler, SE et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346, 393403.
5.Ruxton, CH, Reed, SC, Simpson, MJ et al. (2004) The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. J Hum Nutr Diet 17, 449459.
6.Calder, PC (2006) n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83, 1505S1519S.
7.Singer, P, Shapiro, H, Theilla, M et al. (2008) Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective. Intensive Care Med 34, 15801592.
8.Ikemoto, S, Takahashi, M, Tsunoda, N et al. (1996) High-fat diet-induced hyperglycemia and obesity in mice: Differential effects of dietary oils. Metabolism 45, 15391546.
9.Storlien, LH, Kraegen, EW, Chisholm, DJ et al. (1987) Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 237, 885888.
10.Libby, P, Plutzky, J (2007) Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists. Am J Cardiol 99, 27B40B.
11.Ruzickova, J, Rossmeisl, M, Prazak, T et al. (2004) Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. Lipids 39, 11771185.
12.Flachs, P, Horakova, O, Brauner, P et al. (2005) Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat. Diabetologia 48, 23652375.
13.Kuda, O, Jelenik, T, Jilkova, Z et al. (2009) n-3 Fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet. Diabetologia 52, 941951.
14.Mori, TA, Bao, DQ, Burke, V et al. (1999) Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr 70, 817825.
15.Couet, C, Delarue, J, Ritz, P et al. (1997) Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. Int J Obes (Lond) 21, 637643.
16.Kunesova, M, Braunerova, R, Hlavaty, P et al. (2006) The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiol Res 55, 6372.
17.MacLean, CH, Konica, WA, Morton, SC et al. (2004) Effects of Omega-3 Fatty Acids on Lipids and Glycemic Control in Type II Diabetes and the Metabolic Syndrome and on Inflammatory Bowel Disease, Rheumatoid Arthritis, Renal Disease, Systemic Lupus Erythrematousus, and Osteoporosis. Evidence Report/Technology Assessment no. 89. AHRQ Publication no. 04-E012–1. 2004. Rockville, MD: Agency for Healthcare Research and Quality.
18.Nettleton, JA & Katz, R (2005) n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J Am Diet Assoc 105, 428440.
19.Arterburn, LM, Hall, EB & Oken, H (2006) Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 83, 1467S1476S.
20.Brenna, JT, Salem, N Jr, Sinclair, AJ et al. (2009) alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 80, 8591.
21.Eaton, SB, Eaton, SB III, Konner, MJ et al. (1996) An evolutionary perspective enhances understanding of human nutritional requirements. J Nutr 126, 17321740.
22.Massiera, F, Saint-Marc, P, Seydoux, J et al. (2003) Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern? J Lipid Res 44, 271279.
23.Flachs, P, Rossmeisl, M, Bryhn, M et al. (2009) Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin Sci (Lond) 116, 116.
24.Gonzalez-Periz, A, Horrillo, R, Ferre, N et al. (2009) Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J (Epublication ahead of print version; doi: 10.1096/fj.08–125674).
25.James, MJ, Gibson, RA & Cleland, LG (2000) Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 71, 343S348S.
26.Schwab, JM, Chiang, N, Arita, M et al. (2007) Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447, 869874.
27.Sanderson, LM, de Groot, PJ, Hooiveld, GJ et al. (2008) Effect of synthetic dietary triglycerides: a novel research paradigm for nutrigenomics. PLoS ONE 3, e1681.
28.Luquet, S, Gaudel, C, Holst, D et al. (2005) Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes. Biochim Biophys Acta 1740, 313317.
29.Madsen, L, Petersen, RK & Kristiansen, K (2005) Regulation of adipocyte differentiation and function by polyunsaturated fatty acids. Biochim Biophys Acta 1740, 266286.
30.Neschen, S, Morino, K, Dong, J et al. (2007) n-3 Fatty acids preserve insulin sensitivity in vivo in a PPAR-alpha-dependent manner. Diabetes 56, 10341041.
31.Jump, DB (2004) Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci 41, 4178.
32.Neschen, S, Morino, K, Rossbacher, JC et al. (2006) Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-dependent mechanism in mice. Diabetes 55, 924928.
33.Teran-Garcia, M, Adamson, AW, Yu, G et al. (2007) Polyunsaturated fatty acid suppression of fatty acid synthase (FASN): evidence for dietary modulation of NF-Y binding to the Fasn promoter by SREBP-1c. Biochem J 402, 591600.
34.van Schothorst, EM, Flachs, P, Franssen-van Hal, NL et al. (2009) Induction of lipid oxidation by polyunsaturated fatty acids of marine origin in small intestine of mice fed a high-fat diet. BMC Genomics 10, 110.
35.Jucker, BM, Cline, GW, Barucci, N et al. (1999) Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle: a 13C nuclear magnetic resonance study. Diabetes 48, 134140.
36.Suchankova, G, Tekle, M, Saha, AK et al. (2005) Dietary polyunsaturated fatty acids enhance hepatic AMP-activated protein kinase activity in rats. Biochem Biophys Res Commun 326, 851858.
37.Gabler, NK, Radcliffe, JS, Spencer, JD et al. (2009) Feeding long-chain n-3 polyunsaturated fatty acids during gestation increases intestinal glucose absorption potentially via the acute activation of AMPK. J Nutr Biochem 20, 1725.
38.Carling, D (2004) The AMP-activated protein kinase cascade – a unifying system for energy control. Trends Biochem Sci 29, 1824.
39.Muoio, DM & Newgard, CB (2008) Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 9, 193205.
40.Sastry, PS (1985) Lipids of nervous tissue: composition and metabolism. Prog Lipid Res 24, 69–176.
41.Heath, RB, Karpe, F, Milne, RW et al. (2003) Selective partitioning of dietary fatty acids into the VLDL TG pool in the early postprandial period. J Lipid Res 44, 20652072.
42.Covaci, A, de Boer, J, Ryan, JJ et al. (2002) Distribution of organobrominated and organochlorinated contaminants in Belgian human adipose tissue. Environ Res 88, 210218.
43.Fidler, N, Sauerwald, T, Pohl, A et al. (2000) Docosahexaenoic acid transfer into human milk after dietary supplementation: a randomized clinical trial. J Lipid Res 41, 13761383.
44.Kim, HK, Della-Fera, M, Lin, J et al. (2006) Docosahexaenoic acid inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 preadipocytes. J Nutr 136, 29652969.
45.Stillwell, W, Shaikh, SR, Zerouga, M et al. (2005) Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reprod Nutr Dev 45, 559579.
46.Okuno, M, Kajiwara, K, Imai, S et al. (1997) Perilla oil prevents the excessive growth of visceral adipose tissue in rats by down-regulating adipocyte differentiation. J Nutr 127, 17521757.
47.Gregoire, FM, Smas, CM & Sul, HS (1998) Understanding adipocyte differentiation. Physiol Rev 78, 783809.
48.Darimont, C, Vassaux, G, Ailhaud, G et al. (1994) Differentiation of preadipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II. Endocrinology 135, 20302036.
49.Korotkova, M, Gabrielsson, B, Lonn, M et al. (2002) Leptin levels in rat offspring are modified by the ratio of linoleic to alpha-linolenic acid in the maternal diet. J Lipid Res 43, 17431749.
50.Arenz, S, Ruckerl, R, Koletzko, B et al. (2004) Breast-feeding and childhood obesity – a systematic review. Int J Obes Relat Metab Disord 28, 12471256.
51.Knip, M & Akerblom, HK (2005) Early nutrition and later diabetes risk. Adv Exp Med Biol 569, 142150.
52.Paton, CM & Ntambi, JM (2008) Biochemical and physiological function of stearoyl-CoA desaturase. Am J Physiol Endocrinol Metab (Epublication ahead of print version; doi:10.1152/ajpendo.90897.2008).
53.Lombardo, YB, Hein, G & Chicco, A (2007) Metabolic syndrome: effects of n-3 PUFAs on a model of dyslipidemia, insulin resistance and adiposity. Lipids 42, 427437.
54.Matejkova, O, Mustard, KJ, Sponarova, J et al. (2004) Possible involvement of AMP-activated protein kinase in obesity resistance induced by respiratory uncoupling in white fat. FEBS Lett 569, 245248.
55.Orci, L, Cook, WS, Ravazzola, M et al. (2004) Rapid transformation of white adipocytes into fat-oxidizing machines. Proc Natl Acad Sci U S A 101, 20582063.
56.Zhou, Y-T, Wang, Z-W, Higa, M et al. (1999) Reversing adipocyte differentiation: Implications for treatment of obesity. Proc Natl Acad Sci U S A 96, 23912395.
57.Maassen, JA, Romijn, JA & Heine, RJ (2007) Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus. Diabetologia 50, 20362041.
58.Okuno, A, Tamemoto, H, Tobe, K et al. (1998) Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 101, 13541361.
59.Todoric, J, Loffler, M, Huber, J et al. (2006) Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids. Diabetologia 49, 21092119.
60.Skurnick-Minot, G, Laromiguiere, M, Oppert, JM et al. (2004) Whole-body fat mass and insulin sensitivity in type 2 diabetic women: effect of n-3 polyunsaturated fatty acids. Diabetes 53, 154.
61.Yang, X & Smith, U (2007) Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer? Diabetologia 50, 11271139.
62.Gahceci, M, Gokalp, D, Bahceci, S et al. (2007) The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? J Endocrinol Invest 30, 210214.
63.Kintscher, U & Law, RE (2005) PPARgamma-mediated insulin sensitization: the importance of fat versus muscle. Am J Physiol Endocrinol Metab 288, E287E291.
64.Danforth, E Jr (2000) Failure of adipocyte differentiation causes type II diabetes mellitus? Nature Genetics 26, 13.
65.Abel, ED, Peroni, O, Kim, JK et al. (2001) Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409, 729733.
66.Rossmeisl, M, Jelenik, T, Jilkova, Z et al. (2009) Prevention and reversal of obesity and glucose intolerance in mice by DHA-derivatives. Obesity 17, 10231031.
67.Cinti, S, Mitchell, G, Barbatelli, G et al. (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46, 23472355.
68.Lumeng, CN, Delproposto, JB, Westcott, DJ et al. (2008) Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 57, 32393246.
69.Tobe, K, Fujisaka, S, Ishiki, M et al. (2009) Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Keystone Symposium on Type 2 Diabetes and Insulin Resistance (J3), Fairmont Banff Springs, Alberta, Canada, Abstr. Silverthorne, CO: Keystone Symposia.
70.Bouhlel, MA, Derudas, B, Rigamonti, E et al. (2007) PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 6, 137143.
71.Rossi, AS, Lombardo, YB, Lacorte, JM et al. (2005) Dietary fish oil positively regulates plasma leptin and adiponectin levels in sucrose-fed, insulin-resistant rats. Am J Physiol Regul Integr Comp Physiol 289, R486R494.
72.Flachs, P, Mohamed-Ali, V, Horakova, O et al. (2006) Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed high-fat diet. Diabetologia 49, 394397.
73.Yamauchi, T, Kamon, J, Minokoshi, Y et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8, 12881295.
74.Nawrocki, AR, Rajala, MW, Tomas, E et al. (2006) Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 281, 26542660.
75.Krebs, JD, Browning, LM, McLean, NK et al. (2006) Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int J Obes (Lond) 30, 15351544.
76.Sponarova, J, Mustard, KJ, Horakova, O et al. (2005) Involvement of AMP-activated protein kinase in fat depot-specific metabolic changes during starvation. FEBS Lett 579, 61056110.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Proceedings of the Nutrition Society
  • ISSN: 0029-6651
  • EISSN: 1475-2719
  • URL: /core/journals/proceedings-of-the-nutrition-society
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed